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Infectious Disease Epidemiology Report 
Haemophilus influenzae, Maine 2012 
 
 
 
 
 
 
Background  
The Infectious Disease Epidemiology Program of 
the Maine Center for Disease Control and 
Prevention (Maine CDC) monitors the incidence of 
invasive Haemophilus influenzae (H. influenzae) 
through mandatory reporting by healthcare 
providers, clinical laboratories, and other public 
health partners.  This report summarizes 
surveillance data on cases of invasive H. influenzae 
from 2012.   
 
Haemophilus influenzae disease is caused by 
Haemophilus influenzae bacteria.  It can be spread 
from person to person through droplets in the air 
when a person who is infected sneezes or coughs.  
The bacteria can cause meningitis and infections in 
joints, lungs, and blood. 
Methods 
Cases of invasive H. influenzae are defined as 
persons with isolation of H. influenzae from a 
normally sterile site (e.g. blood or cerebrospinal 
fluid or, less commonly, joint, pleural, or pericardial 
fluid).  Standardized case report forms were 
completed for each case in 2012.  Serotyping was 
performed on H. influenzae isolates at Maine’s 
Health and Environmental Testing Laboratory 
(HETL).  Rates were calculated using 2012 US 
census population estimates.   
Results 
A total of 23 cases of invasive H. influenzae were 
reported in Maine in 2012. This is three fewer 
cases than were reported in 2011.  The 2012 rate 
of H. influenzae in Maine was 1.7 cases per 
100,000 population which is a decrease from 2.0 in 
2011 (Figure 1).  The 2012 US rate was 1.1 cases 
per 100,000 population. 
 
 
 
 
 
 
 
 
 
Figure 1: Rate of invasive H. influenzae by year – 
Maine, 2007-2012 
 
 
The age range of all cases was 6 days to 93 years, 
and the median age was 66 years. Three cases 
were H. influenzae serotype b (Hib) (Table 1).  
There were no cases of Hib in children. 
 
 
Table 1: Number of invasive H. influenzae cases by 
age and serotype – Maine, 2012 
 
  Serotype  
Age 
(years) 
B Non-B Non-
Typeable 
Unknown* Total 
<5 0 1 1 0 2 
5-17 0 0 0 0 0 
18-34 0 0 1 0 1 
35-44 0 1 0 0 1 
45-64 1 3 2 0 6 
>65 2 6 4 1 13 
Total 3 11 8 1 23 
*Unknown due to sample not being sent to HETL for testing.  
 
 
Of the 23 invasive H. influenzae cases reported in 
2012, 9 had bacteremia, 17 had pneumonia, 2 had 
meningitis, and 1 had sepsis. Four deaths were 
associated with invasive H. influenzae disease in 
2012. 
 
Invasive H. influenzae disease was identified 
among residents in 11 of 16 Maine counties (Figure 
2).  
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Figure 2: Invasive H. influenzae cases – Maine, 2012 
(N=23) 
 
 
Discussion 
H. influenzae serotype b is vaccine preventable.  In 
2012, there were no Hib cases identified in infants 
or young children in Maine. Unvaccinated 
household and child care contacts of a known Hib 
case are at higher risk for disease because the 
bacteria are spread from person to person by 
airborne droplets through coughing or sneezing.  
 
Prophylaxis with antibiotics is recommended for all 
household members and close contacts of 
someone diagnosed with Hib disease only if there 
is  
• at least one unvaccinated child under 4 
years of age or  
• a child or adult with a weak immune system 
in the home.  
 
A vaccine against Hib is available in the United 
States and is recommended for the following 
individuals: 
• All infants beginning at 2 months of age. 
 
 
• Persons older than 59 months of age 
who have high-risk conditions including 
sickle cell disease, HIV/AIDS, asplenia, 
bone marrow transplant, or are immune 
compromised.  
 
Hib vaccine is not recommended for healthy 
persons older than 59 months of age. 
 
Maintaining high vaccination rates, particularly 
among children in child care settings, is important 
to prevent Hib.  There are no vaccines for use 
against non-serotype b disease. 
 
All cases of invasive H. influenzae disease in Maine 
must be reported by calling 1-800-821-5821, or by 
faxing reports to 1-800-293-7534. For more 
information, contact your healthcare provider or 
local health center.   
 
Additional information about H. influenzae can be 
found at: 
• Maine CDC 
http://www.maine.gov/dhhs/mecdc/infectiou
s-disease/epi/airborne/haemophilus.shtml 
• Federal CDC 
http://www.cdc.gov/vaccines/vpd-
vac/hib/default.htm 
 
 
 
